FIELD: chemistry.
SUBSTANCE: invention relates to the mixture of sulfated oligosaccharide having common structure of polyose that is included in heparin composition with average molecular mass ranging from 1500 to 3000 Da and proportion of anti-Xa/anti-IIa more than 30, to the method of their production and antithrombotic pharmaceutical compositions containing them.
EFFECT: production of the pharmaceutical compositions containing sulfated oligosaccharide that has antithrombotic activity.
31 cl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
MIXTURES OF OLIGOSACCHARIDES, WHICH ARE DERIVATIVES OF HEPARIN, METHOD OF OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2004 |
|
RU2346005C2 |
METHOD FOR OBTAINING NADROPARIN CALCIUM | 2020 |
|
RU2753678C1 |
METHOD OF OBTAINING LOW-MOLECULAR HEPARIN | 2012 |
|
RU2512768C1 |
PROCESS FOR LOW MOLECULAR WEIGHT HEPARIN PREPARATION | 2016 |
|
RU2639574C2 |
PURIFIED HEPARIN FRACTION, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION CONTAINING ON SAID | 1994 |
|
RU2133253C1 |
METHOD FOR PRODUCING LOW MOLECULAR WEIGHT HEPARIN | 2017 |
|
RU2670767C9 |
METHOD OF PRODUCING LOW-MOLECULAR HEPARIN | 2020 |
|
RU2725545C1 |
PHENOXYCARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERY OF ACTIVE SUBSTANCES | 2000 |
|
RU2300516C2 |
DERMATAN SULFATE OR ITS SALT, ANTITHROMBOTIC AGENTS, METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS, METHOD OF PROPHYLAXIS OR TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME, METHOD OF MYOCARDIUM INFARCTION TREATMENT | 1994 |
|
RU2153506C2 |
PROCESS OF PRODUCTION OF O-ACYLATED GLUCOS-AMINOGLYCANES | 0 |
|
SU1831487A3 |
Authors
Dates
2008-08-27—Published
2003-10-08—Filed